Anixa Biosciences Inc.
ANIX
Anixa Biosciences, Inc. is a biotechnology company developing therapies and vaccines that are focused on critical unmet needs in oncology. Our therapeutics program consists of the development of liraltagene autoleucel ( lira-cel ), a chimeric endocrine receptor-T cell therapy, which is a novel form of chimeric antigen receptor-T cell ( CAR-T ) technology, initially focused on treating …
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$10M
▲ +13.0% YoY
Op. Margin
–
ROIC
-57.87%
▼ -3.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$7M
▲ +2.2% YoY
Op. Cash Flow (TTM)
-$7M
▲ +2.2% YoY
Net Debt
-$14M
Net Cash Position
Cash & Equiv.
$14M
5Y CAGR: -10.3%
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with ANIX
Held by ETFs
ANIX is in 1 US ETF. The largest of them, with ANIX's weight in each:
Anixa Biosciences (ANIX) in three numbers
Questions about Anixa Biosciences
Is Anixa Biosciences a high-quality business?
Anixa Biosciences scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is net debt at -$14M, and its weakest is return on capital at -57.9%. The Quality tab shows every check against its target.
Does Anixa Biosciences (ANIX) pay a dividend?
No. Anixa Biosciences (ANIX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 9 Sept 2026 (period ending 31 Jul 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in ANIX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ANIX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.